Van Beek J - Search Results

1

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Van Nueten JM, Janssen PA, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM. Van Nueten JM, et al. Among authors: van beek j. J Pharmacol Exp Ther. 1981 Jul;218(1):217-30. J Pharmacol Exp Ther. 1981. PMID: 6113280

2

The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances.

Van Nueten JM, Van Beek J, Janssen PA. Van Nueten JM, et al. Among authors: van beek j. Arzneimittelforschung. 1978;28(11):2082-7. Arzneimittelforschung. 1978. PMID: 582911

3

Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle.

Van Nueten JM, Van Beek J, Janssen PA. Van Nueten JM, et al. Among authors: van beek j. Arch Int Pharmacodyn Ther. 1978 Mar;232(1):42-52. Arch Int Pharmacodyn Ther. 1978. PMID: 666459

4

Effect of Ca2+-entry blockade and serotonergic antagonism on contractions of hypoxic isolated canine coronary arteries.

Van Nueten JM, Van Beek J, Vanhoutte PM. Van Nueten JM, et al. Among authors: van beek j. Arch Int Pharmacodyn Ther. 1983 Sep;265(1):172-6. Arch Int Pharmacodyn Ther. 1983. PMID: 6651402

5

Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.

Van Neuten JM, Van Beek J, Vanhoutte PM. Van Neuten JM, et al. Among authors: van beek j. J Pharmacol Exp Ther. 1980 Apr;213(1):179-87. J Pharmacol Exp Ther. 1980. PMID: 7359366

6

Inhibitory effect of ketanserin on ergonovine-induced contractions of isolated canine coronary arteries.

Van Beek J, Janssen PA, Van Nueten JM. Van Beek J, et al. Among authors: van nueten jm. Arch Int Pharmacodyn Ther. 1983 Sep;265(1):167-71. Arch Int Pharmacodyn Ther. 1983. PMID: 6651401 No abstract available.

7

Hypoxia and spasms in the cerebral vasculature.

Van Nueten JM, De Ridder W, Van Beek J. Van Nueten JM, et al. Among authors: van beek j. J Cereb Blood Flow Metab. 1982;2 Suppl 1:S29-31. J Cereb Blood Flow Metab. 1982. PMID: 7085793 No abstract available.

8

Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.

Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L. Villa P, et al. Among authors: van beek j. J Cereb Blood Flow Metab. 2007 Mar;27(3):552-63. doi: 10.1038/sj.jcbfm.9600370. Epub 2006 Jul 12. J Cereb Blood Flow Metab. 2007. PMID: 16835629

9

Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo.

Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, Mengozzi M, Viviani B, Corsini E, Marinovich M, Torup L, Van Beek J, Leist M, Brines M, Cerami A, Ghezzi P. Mennini T, et al. Among authors: van beek j. Mol Med. 2006 Jul-Aug;12(7-8):153-60. doi: 10.2119/2006-00045.Mennini. Mol Med. 2006. PMID: 17088947 Free PMC article.

10

Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.

Montero M, Poulsen FR, Noraberg J, Kirkeby A, van Beek J, Leist M, Zimmer J. Montero M, et al. Among authors: van beek j. Exp Neurol. 2007 Mar;204(1):106-17. doi: 10.1016/j.expneurol.2006.09.026. Epub 2006 Dec 8. Exp Neurol. 2007. PMID: 17157835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page